Current treatment strategies for RA include NSAIDs, glucocorticoids, disease-modifying anti-rheumatic drugs (DMARDs), such as methotrexate, and biologic response modifiers, for example, the blockade of TNF and IL-6 (66). This evidence concerns the gene TNF and rheumatoid arthritis.